In addition to genetic alterations, PDAC features a dysregulated immune environment with tumorigenic regulatory T cells, intratumoral macrophages producing interleukin 6 (IL-6), and cancer-associated fibroblasts (CAFs) that promote tumor progression [26]. Here, IL6 is linked to cancer.